Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vynleads is a publicly traded digital health and wellness technology company focused on AI-powered metabolic health support. The company provides lifestyle-first educational programs, coaching, nutrition guidance, and health tracking aimed primarily at people with prediabetes or type 2 diabetes. Its flagship offering is the Done With Diabetes program, delivered alongside its Lifestyle Blueprint platform and Dr. Smith AI Coach. Rather than developing therapeutics, Vynleads markets consumer and enterprise wellness solutions for individuals, health systems, and payers seeking chronic disease prevention and management tools. The business appears to be commercial-stage, with its services centered on behavior change, personalized guidance, and metabolic health improvement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vynleads.